*Knivsberg, A.M., et al., A randomized, controlled study of dietary intervention in autistic syndromes
While GLP-1 medications may cause headaches in some users, some early research is exploring whether GLP-1related mechanisms could influence certain headache conditions, particularly those living with obesity-related migraine or a condition called idiopathic intracranial hypertension (IIH) (which causes chronic headaches due to elevated pressure around the brain)
Retatrutide is part of the next generation
What matters most is: The receptor pathways activated (single, dual, or triple agonism) The degree of weight loss achieved at clinical endpoints The tolerability profile at each dose escalation By these measures, Retatrutides dosing strategy has set a new benchmark for weight-loss drugs currently under development
Raz R, Weisskopf MG, Davidovitch M, Pinto O, Levine H